Biomarkers in Alzheimer's disease clinical trials: 2025
Abstract Biomarkers play an important role in Alzheimer's disease (AD) clinical trials in several contexts of use, including defining trial eligibility and serving as outcome measures. Utilizing clinicaltrials.gov, a registry of clinical trials, we assessed biomarker usage across all active AD disea...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-01-01
|
| Col·lecció: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/trc2.70217 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|